Cargando…
Serum Müllerian inhibiting substance levels are lower in premenopausal women with breast precancer and cancer
BACKGROUND: In preclinical studies, müllerian inhibiting substance (MIS) has a protective affect against breast cancer. Our objective was to determine whether serum MIS concentrations were associated with cancerous or precancerous lesions. Blood from 30 premenopausal women was collected and serum ex...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130667/ https://www.ncbi.nlm.nih.gov/pubmed/21615907 http://dx.doi.org/10.1186/1756-0500-4-152 |